Mirion Technologies/$MIR
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Mirion Technologies
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.
- Ticker
- $MIR
- Sector
- Digital Hardware
- Primary listing
- NYSE
- Employees
- 3,281
- Headquarters
- Atlanta, United States
- Website
- www.mirion.com
MIR Metrics
BasicAdvanced
$4.4B
171.41
$0.11
1.10
-
Price and volume
Market cap
$4.4B
Beta
1.1
52-week high
$29.83
52-week low
$14.04
Average daily volume
4.5M
Financial strength
Current ratio
3.018
Quick ratio
2.374
Long term debt to equity
0.673
Total debt to equity
0.677
Interest coverage (TTM)
2.33%
Profitability
EBITDA (TTM)
233
Gross margin (TTM)
48.12%
Net profit margin (TTM)
2.69%
Operating margin (TTM)
7.37%
Effective tax rate (TTM)
24.44%
Revenue per employee (TTM)
$330,000
Management effectiveness
Return on assets (TTM)
1.42%
Return on equity (TTM)
1.63%
Valuation
Price to earnings (TTM)
171.408
Price to revenue (TTM)
4.153
Price to book
2.47
Price to tangible book (TTM)
-7.47
Price to free cash flow (TTM)
26.685
Free cash flow yield (TTM)
3.75%
Free cash flow per share (TTM)
0.688
Growth
Revenue change (TTM)
19.65%
Earnings per share change (TTM)
5.58%
3-year revenue growth (CAGR)
11.05%
3-year earnings per share growth (CAGR)
-55.62%
What the Analysts think about MIR
Analyst ratings (Buy, Hold, Sell) for Mirion Technologies stock.
Analyst projections of the future price of Mirion Technologies stock.
Bulls say / Bears say
Core orders rose 62% year on year in Q3, including a 105% rise in nuclear power orders, and backlog reached $1.25 billion. That backlog gives Mirion a sizeable base to convert into sales over the next two years. (The Motley Fool)
Organic revenue growth reached 6.5% in Q3, and Mirion raised its 2026 organic growth outlook to 7%–8% from 5%–7%. Management expects a further acceleration in Q4 as the backlog converts. (Mirion Technologies)
Year-to-date adjusted free cash flow doubled to $107 million, prompting Mirion to raise its full-year cash-flow forecast. Management expects net leverage to fall to about 2.6 times by year-end, which could strengthen its capacity to invest and repay debt. (Mirion Technologies)
Despite raising revenue and cash-flow forecasts, Mirion lowered the top end of its adjusted EBITDA range and set adjusted EPS guidance below analyst expectations. This points to weaker near-term profit conversion than the sales outlook alone suggests. (Investing.com)
Management withdrew its previous 2028 margin target, saying Medical growth has been muted and margin expansion at Paragon will take longer than expected because of higher product-development spending. Continued AI and cybersecurity investment also adds near-term cost pressure. (The Motley Fool)
Net leverage stood at 3.1 times at quarter-end, and the planned reduction to about 2.6 times assumes no further share buybacks or acquisitions in Q4. That leaves Mirion with less room to pursue deals or return cash if debt reduction takes priority. (The Motley Fool)
Data summarised monthly by Lightyear AI. Last updated on 29 Oct 2026.
MIR Financial Performance
Revenues and expenses
MIR Earnings Performance
Company profitability
Upcoming events
No upcoming events
MIR News
AllArticlesVideos
What Mirion Technologies (MIR) Said on Its Q3 Earnings Call
MarketBeat3 days ago
Mirion Extends Support of IAEA Mission to Advance Cancer Care Globally through Rays of Hope Donation
Business Wire2 weeks ago
Mirion Announces Earnings Release and Conference Call Date for Third Quarter 2026
Business Wire2 weeks ago
Funds containing MIR
AllUSDEURGBP
Fund name | Fund size | $MIR weighting |
|---|---|---|
Invesco Defence Innovation£DFNX | $161M | 1.38% |
Invesco Defence Innovation$IDFN | $161M | 1.38% |
iShares Digital Security€L0CK | $1.9B | 0.82% |
iShares S&P SmallCap 600$IDP6 | $3.2B | 0.26% |
iShares S&P Small Cap 600£ISP6 | $3.2B | 0.26% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.